Bright Minds Biosciences (DRUG) Prepaid Assets (2020 - 2026)
Bright Minds Biosciences (DRUG) reported Prepaid Assets of $1.1 million for Q1 2026, up 727.36% on a YoY basis from $128763.0 in Q1 2025, and up 696.13% quarter-over-quarter from -$178709.4 in Q4 2025.
Bright Minds Biosciences (DRUG) Prepaid Assets (2020 - 2026) Analysis & Trends
Bright Minds Biosciences has reported Prepaid Assets for 7 years, with the latest figure at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 727.36% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 727.36% YoY), and the FY2025 full-year result was $717850.7, up 352.05% from the prior year.
- Prepaid Assets for Q1 2026 stood at $1.1 million, up from -$178709.4 in the prior quarter.
- The five-year high for Prepaid Assets was $1.1 million in Q1 2026, with the low at -$178709.4 in Q4 2025.
- Historically, Prepaid Assets has averaged $163145.2 across 5 years, with a median of $43267.4 in 2024.
- The largest YoY upside for Prepaid Assets was 2183.36% in 2025 against a maximum downside of 513.04% in 2025.
- Bright Minds Biosciences' Prepaid Assets stood at $4620.6 in 2022, then plunged by 30.39% to $3216.5 in 2023, then surged by 1245.16% to $43267.4 in 2024, then plunged by 513.04% to -$178709.4 in 2025, then surged by 696.13% to $1.1 million in 2026.
- The last three Prepaid Assets figures came in at $1.1 million (Q1 2026), -$178709.4 (Q4 2025), and $717850.7 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Bright Minds Biosciences | 16.28 Bn | 16.22 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | -178,709.38 |
| Sep 30, 2025 | 717,850.71 |
| Jun 30, 2025 | 511,253.92 |
| Mar 31, 2025 | 128,762.99 |
| Dec 31, 2024 | 43,267.35 |
| Sep 30, 2024 | 158,799.89 |
| Jun 30, 2024 | 22,390.45 |
| Mar 31, 2024 | 9,186.62 |
| Dec 31, 2023 | 3,216.53 |
| Sep 30, 2023 | 20,656.31 |
| Jun 30, 2023 | 16,894.60 |
| Mar 31, 2023 | -10,660.50 |
| Dec 31, 2022 | 4,620.60 |
| Sep 30, 2022 | 126,075.32 |
| Jun 30, 2022 | 68,957.66 |
| Mar 31, 2022 | 65,565.93 |
| Dec 31, 2021 | 20,667.99 |
| Sep 30, 2021 | 133,625.21 |
| Jun 30, 2021 | -40,503.08 |